A network analysis of COVID-19 mRNA vaccine patents | Nature Biotechnology
A network analysis of COVID-19 mRNA vaccine patents | Nature Biotechnology: A preliminary network analysis highlights the complex intellectual property landscape behind mRNA-based COVID-19 vaccines.
No comments:
Post a Comment